173 related articles for article (PubMed ID: 26434996)
1. Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells.
Hernández-Reséndiz I; Román-Rosales A; García-Villa E; López-Macay A; Pineda E; Saavedra E; Gallardo-Pérez JC; Alvarez-Ríos E; Gariglio P; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2015 Dec; 1853(12):3266-78. PubMed ID: 26434996
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53
Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
[TBL] [Abstract][Full Text] [Related]
3. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.
Rodríguez-Enríquez S; Carreño-Fuentes L; Gallardo-Pérez JC; Saavedra E; Quezada H; Vega A; Marín-Hernández A; Olín-Sandoval V; Torres-Márquez ME; Moreno-Sánchez R
Int J Biochem Cell Biol; 2010 Oct; 42(10):1744-51. PubMed ID: 20654728
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.
Marín-Hernández Á; Gallardo-Pérez JC; Hernández-Reséndiz I; Del Mazo-Monsalvo I; Robledo-Cadena DX; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2017 Jun; 232(6):1346-1359. PubMed ID: 27661776
[TBL] [Abstract][Full Text] [Related]
5. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
[TBL] [Abstract][Full Text] [Related]
6. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism transition in multi-cellular human tumor spheroids.
Rodríguez-Enríquez S; Gallardo-Pérez JC; Avilés-Salas A; Marín-Hernández A; Carreño-Fuentes L; Maldonado-Lagunas V; Moreno-Sánchez R
J Cell Physiol; 2008 Jul; 216(1):189-97. PubMed ID: 18264981
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells.
Rodríguez-Enríquez S; Hernández-Esquivel L; Marín-Hernández A; El Hafidi M; Gallardo-Pérez JC; Hernández-Reséndiz I; Rodríguez-Zavala JS; Pacheco-Velázquez SC; Moreno-Sánchez R
Int J Biochem Cell Biol; 2015 Aug; 65():209-21. PubMed ID: 26073129
[TBL] [Abstract][Full Text] [Related]
9. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
10. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
11. Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells.
Plecitá-Hlavatá L; Ježek J; Ježek P
J Bioenerg Biomembr; 2015 Dec; 47(6):467-76. PubMed ID: 26449597
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia, Mn-SOD and H(2)O(2) regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells.
Rieber M; Strasberg-Rieber M
Biochem Pharmacol; 2012 Dec; 84(12):1563-70. PubMed ID: 22982566
[TBL] [Abstract][Full Text] [Related]
13. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
[TBL] [Abstract][Full Text] [Related]
14. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development.
Jezek P; Plecitá-Hlavatá L; Smolková K; Rossignol R
Int J Biochem Cell Biol; 2010 May; 42(5):604-22. PubMed ID: 19931409
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level.
Amellem O; Stokke T; Sandvik JA; Smedshammer L; Pettersen EO
Exp Cell Res; 1997 May; 232(2):361-70. PubMed ID: 9168813
[TBL] [Abstract][Full Text] [Related]
17. Glucose plays a main role in human fibroblasts adaptation to hypoxia.
Baracca A; Sgarbi G; Padula A; Solaini G
Int J Biochem Cell Biol; 2013 Jul; 45(7):1356-65. PubMed ID: 23538299
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
Fu Z; Chen D; Cheng H; Wang F
Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial oxidative phosphorylation became functional under aglycemic hypoxia conditions in A549 cells.
Öğünç Keçeci Y; İncesu Z
Mol Biol Rep; 2022 Sep; 49(9):8219-8228. PubMed ID: 35834035
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
